Skip to main content

Table 6 Analysis of PLR, MLR and SII in general population

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Parameter

ESCC patients

Tumor-free people

PLR

174.72

117.01

MLR

0.21

0.30

SII

829.37

376.76

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us